HDAC9 and neoplasm: Moreover, HDAC inhibition has the potential to suppress tumor cells’ capacity to fluctuate between different phenotypes, especially the reversible transdifferentiation from an epithelial to a more mesenchymal state, achieved via activation of epithelial-to-mesenchymal transition, which enhances their invasive and metastatic capacity [60].